http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111888463-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-165
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
filingDate 2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111888463-B
titleOfInvention Thymosin beta 4 medicinal preparation for treating depression, preparation method and application thereof
abstract The invention discloses a thymosin beta 4 medicinal preparation for treating depression, a preparation method and application thereof, and belongs to the technical field of disease treatment. The invention mainly induces the mouse depression-like behavior by establishing a chronic social contusion stress model (CSDS), and the model has the advantages that the model simulates the social attributes in human chronic stress, and after the model is nasally administered with T beta 4 for 7 consecutive days, the depression level is evaluated by the behavioral tests such as Social Interaction Test (SIT), Tail Suspension Test (TST), sugar water preference test (SPT) and the like, and the result shows that the T beta 4 has the rapid antidepressant effect in the mouse and can reverse the CSDS-induced depression-like behavior within 7 days.
priorityDate 2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID781334
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81814
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601108
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7114
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 34.